18
NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 UNITED STATES DEPARTMENT OF VETERANS AFFAIRS

NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Embed Size (px)

Citation preview

Page 1: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

NYU Medical Grand Rounds Clinical Vignette

Daniel P. Eiras, MD, MPH

PGY2

December 1, 2010

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 2: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• 49 year old Malaysian woman who presented to the Bellevue Clinic with a right breast mass that she had noticed for one month

Chief Complaint

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 3: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• The patient was in her usual state of health until several months prior to admission when she noticed a painless lump in her right axilla

•One month prior to admission, she noticed a second lump in her right breast

•Given the above findings she presented to Bellevue Clinic for evaluation

History of Present Illness

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 4: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Additional History

•Past Medical History:•G5P3 with two miscarriages

•Past Surgical History•None

•Social History:•The patient works as a hair stylist. She has no history of tobacco, alcohol or drug use.

•Family History:•No history of cancer

•Allergies: •No known drug allergies

•Medications:•None

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 5: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Physical Examination•General: Comfortable, appears stated age

•T: 97.7, BP: 138/90, HR: 74, RR: 16, O2 sat: 98% on room air

•Breast Exam:• Palpable 2 x 2.5cm breast mass at the 10 o’clock position• Palpable 3cm oblong lymph node in the right axilla

•Remainder of physical exam was normal

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 6: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Laboratory Findings

•CBC: within normal limits

•Basic metabolic panel: within normal limits

•Hepatic panel: within normal limits

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 7: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• Breast mass secondary to breast cancer, versus breast cyst, fibroadenoma, or lipoma.

Differential Diagnosis

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 8: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Diagnostic Mammogram

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 9: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Other Studies

•Breast ultrasound •4.1cm lobulated mass in the right axillary tail•1.7cm irregular mass at the 10 o'clock position in the right breast

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 10: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Interim History

•A fine needle aspirate of the two masses was performed and was positive for adenocarcinoma

•A core biopsy revealed poorly differentiated invasive ductal carcinoma

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 11: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Additional Studies

•Immunohistochemistry -Negative for estrogen and progesterone receptors

-Human Epidermal growth factor Receptor 2 (Her2/Neu) score was 2+ (equivocal)

-Ki-67 proliferation index was 85% (high)

-Fluorescence in situ hybridization for Her2/Neu was negative

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 12: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Other Studies

•Positron Emission Tomography/CAT Scan -2 x 1.7cm malignant lesion in the right breast (standardized uptake value 8.5)

-Multiple metastatic lymph nodes

(maximum standardized uptake value 10.4)

-Negative for distant metastases

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 13: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• T2N2M0, stage IIIA, ER-PR-Her2 triple negative, poorly differentiated, invasive ductal adenocarcinoma

Working Diagnosis

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 14: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• The patient was enrolled in neoadjuvant protocol– She received taxol 30mg/m2 twice a week for 6

weeks, with concurrent radiation therapy for 6 weeks– This was followed by an additional 6 weeks of taxol

Interim History

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 15: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

Follow-up Diagnostic Mammogram

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 16: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• The patient underwent a right modified radical mastectomy– Pathology of 11 lymph nodes was negative for tumor

• She then began adjuvant chemotherapy twice weekly for four cycles – She received doxorubicin 60mg/m2, cyclophosphamide

600mg/m2 as well as neupogen x 5 for each cycle

Interim History

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 17: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• The patient has been in complete pathological remission for seven months.

Interim History

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS

Page 18: NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS

• T2N2M0, stage IIIA, (Surgical staging T0N0M0), ER-PR-Her2 triple negative, poorly differentiated, invasive ductal adenocarcinoma, treated with neoadjuvant chemotherapy, surgery, and adjuvant chemotherapy, now in complete pathological remission.

Final Diagnosis

UNITED STATES

DEPARTMENT OF VETERANS

AFFAIRS